AI biomarker scoring, built for routine practice.

CE-IVD decision support delivering reproducible breast and immuno-oncology biomarker quantification for the reporting pathologist.

Book a clinical demo

Diagnostic Suites

All our clinical suites, one platform

Each suite is built for speed, accuracy, and clinical confidence — and lives inside the same reporting workflow your team already uses.

Explore suite

Breast Suite

IHC scoring for HER2, Ki-67, ER and PR — standardised across stains, scanners, and reporting habits.

Explore suite

Immuno-Oncology Suite

PD-L1, p53, CD4/CD8 and TRBC1/CD3 — single-cell precision for immuno-oncology decisions.

Your indication

Talk to a pathologist

Any other indication

Our "one model" architecture scales to additional clinical assays. Talk to us about custom development for your specific protocol.

Recognition Built on Clinical Reality

Our technology meets the standards of clinical routine and regulatory oversight. These certifications and milestones reflect a focus on safety, reproducibility, and global deployment.

5 CE-IVD models

Standardized Breast Diagnostics

Breast Suite

A comprehensive AI suite for breast cancer diagnosis — HER2 (including low and ultralow), Ki-67, ER, and PR — with reproducible scoring across multiple biomarkers and clinical use cases.

Immuno-Oncology Diagnostics

Immuno-Oncology Suite

Cell-type recognition within staining context for PD-L1, plus quantitative readouts for p53, CD4/CD8, and TRBC1/CD3 — built for borderline and heterogeneous cases where visual estimation varies.

Elevate your clinical workflow

Whether you're starting to scale your slide capacity with a single AI module, or deploying a full digital pathology environment, our methodical approach to validation is your dedicated partner in operations approved.

From slide ingest to sign-out, every step is reproducible, audit-tracked, and built to slot into your existing LIS and scanner setup — so your team spends less time on manual review and more on the cases that need it.

Contact

Built for throughput

One reproducible path, every case

Slide ingest
WSI · 40× scan
01
AI analysis
Region segmentation
02
Reproducible score
Biomarker readout
03
Sign-out ready
Audit-tracked report
04

What labs gain from AI-assisted reporting

Faster results without sacrificing quality. Better compliance without extra burden. Confidence in every report.

Book a demo

Faster turnaround times
Reduce case processing from hours to minutes.
Reproducible results
AI consistency removes observer variability.
Regulatory confidence
ISO certifications and audit trails built in.

FAQ

Deployment, validation, and how the modules fit into your existing workflow.

Modules behave as decision support inside the existing reporting workflow. Cases reach the platform via direct scanner integration; the pathologist opens the slide in their viewer, the module returns quantitative outputs and an annotated overlay, and the final score remains a pathologist decision.

Deployment is phased — assessment, design, pilot, validation, go-live — and is configured to match the security, data governance, and integration requirements of the host institution. Cloud, on-prem, and hybrid options are supported.

The CE-IVD modules cover IHC for the most clinically relevant biomarkers (HER2, Ki-67, ER, PR, PD-L1, p53, etc.). Research-only modalities and custom-trained models are supported through the research platform.

Clinical modules are CE-IVD certified. Local validation against the laboratory's own staining protocol, scanner, and case mix is part of every clinical engagement before routine use.

Still wondering?

Don't waste time in uncertainty.

Our team is ready to walk through implementation details.

Get in touch

Speak with our pathology team

Tell us about your laboratory, the case mix you work with, and the workflow you want to evolve. We will tailor the demonstration and validation plan to match your exact protocols, scanners, and reporting habits.

AI biomarker scoring, built for routine practice.